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CONCERNING
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SCOTT E. HENKE, Caesar Kleberg Wildlife Research Institute, Texas A&M UniversityKingsville, Kingsville, TX, USA
Abstract: Rabies is an important zoonotic disease in Texas and thousands of people each year
either request or require rabies prophylaxis because they have ‘high risk’ jobs or are exposed to
the disease. After experiencing difficulty in receiving rabies prophylaxis from physicians, we
conducted a survey of Texas medical providers to assess their knowledge of rabies vaccine
procedures and their experience with rabies vaccines. Most providers in Texas (>95% of 297)
rarely saw patients for rabies prophylaxis; therefore, providers have minimal, if any, experience
with the procedures of acquiring and administering the vaccine. Providers varied greatly in their
responses to our questions of where to acquire the vaccine, how and where to administer the
vaccine, and where to acquire information about the vaccine. State and local health departments
should target medical clinics and physician associations as outlets to disseminate information
regarding rabies, rabies prophylaxis, and treatment.
Key words: medical providers, physicians, prophylaxis, rabies, survey, Texas, vaccine
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approximately 16,000 - 39,000 people in the
United States receive post-exposure rabies
prophylaxis (Krebs et al. 1998). In addition,
pre-exposure rabies vaccinations should be
offered to persons in high-risk groups, such
as veterinarians, animal handlers, wildlife
biologists, etc. Pre and post-exposure rabies
prophylaxis is routinely available with a
physician’s
prescription.
However,
knowledge of physicians as to the process to
acquire rabies vaccine (i.e., pre and post
exposure) is uncertain.
We became
involved in this issue when we had difficulty
in acquiring pre-exposure rabies vaccine for
ourselves and employees.
Medical
providers we contacted in Texas either
denied services, were hesitant, or unsure
how to acquire rabies prophylaxis.
Therefore, our objectives were to compare
knowledge of medical providers concerning

INTRODUCTION
Rabies is an important zoonotic viral
disease in the United States that causes an
acute encephalitis, which if left untreated,
has a prognosis that is almost always fatal.
Epizootics of rabies have been reported in
raccoons (Procyon lotor) along the Atlantic
coastal states (Hanlon et al. 1989), in red fox
(Vulpes vulpes) from northeastern states
(Johnston et al. 1988), in striped skunks
(Mephitis mephitis) from central states
(Rupprecht et al. 1996), in coyotes (Canis
latans) in southern Texas (Farry et al.
1998a, b), in gray fox (Urocyon
cinerargenteus) in central Texas (Steelman
et al. 2000), and in bats sporadically
throughout the continental United States
(Rupprecht et al. 1996).
Human exposure to rabies has
occurred in each epizootic. Every year
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from each city, unless that city had fewer
clinics that were willing to participate.
Medical providers that occurred in small
cities within the rabies endemic zone
included offices in Raymondville/Port
Isabelle (N = 7), Junction (N = 10),
Fredericksburg (N = 10), Fort Stockton (N =
5), Harlengen (N = 6), Kingsville (N = 10),
Kerrville (N = 10), and Stephenville (N =
10); medical providers that occurred in large
cities within the rabies endemic zone
included offices in McAllen (N = 10),
Laredo (N = 10), Austin (N = 10), San
Antonio (N = 10), Houston (N = 10), Dallas
(N = 10), Ft. Worth (N = 10), Abilene (N =
10), and Corpus Christi (N = 10); medical
providers that occurred in small cities
outside the rabies endemic zone included
offices in Corsicana (N = 9), Galveston (N =
10), San Marcos (N = 10), Lufkin (N = 10),
Georgetown (N = 10), Bay City (N = 10),
and Victoria (N = 10); medical providers
that occurred in large cities outside the
endemic rabies zone included offices in
Wichita Falls (N = 10), Amarillo (N = 10),
Lubbock (N = 10), El Paso (N = 10),
Midland (N =10), Odessa (N = 10), and
Waco (N = 10) (Figure 1). Physicians or
nurses were asked a series of questions
concerning rabies pre-exposure and post
exposure vaccines (Table 1), and their
responses were recorded.
Answers of respondents were
analyzed using G-tests (Sokal and Rohlf
1981) to compare the mean proportion of
categorical responses given between
respondents by region (inside or outside the
rabies endemic zone), city size (large or
small), and interactions of main effects.
Statistical tests were considered significant
at P < 0.05. Unless otherwise specified,
data were pooled and graphically
represented
due
to
non-significant
differences between regions and city sizes.

rabies vaccines between physicians whose
practice was located within and outside
historic Oral Rabies Vaccination Program
(ORVP) baiting zones in Texas, and to
compare knowledge of medical providers
concerning rabies vaccine between small
and large cities within Texas. Houston,
Dallas/Ft.Worth, and Austin contain large
concentrations of skunk and bat rabies
endemic in those populations and for which
ORVP is not available. Due to mass media,
we have included them inside the rabies
zone, although no bait has ever been placed
there. Our hypothesis was that medical
providers whose practices occurred within
the rabies ORVP zones would potentially
have more requests for pre and postexposure rabies vaccines; therefore, would
be more familiar with procedures for
acquiring
and
administering
rabies
prophylaxis.
METHODS
Medical providers were contacted
throughout Texas and either the physician or
nurse was interviewed concerning their
knowledge of rabies prophylaxis and post
exposure vaccine. Since many insurance
companies require an initial visit to a
primary care physician, medical providers
surveyed were limited to those in family
practice. Medical providers were placed
into one of four categories: either within or
outside the rabies endemic zone and either
in a small (<60,000 population) or large
(>100,000 population) city. Rabies endemic
zone was defined as areas that occurred
within the historic bait drop zones for
coyotes, gray foxes, and skunks in Texas
(Bradley
Hicks,
USDA-APHIS-WS,
personal
communication).
Medical
providers were randomly selected from the
yellow page listings from cities that met our
size stipulation. Medical provider selection
continued until 10 clinics were interviewed
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Figure 1. Locations of medical providers who participated in our survey of rabies vaccines. Red stars are
cities within the rabies endemic zone; yellow stars are outside the rabies endemic zone; big-sized stars
represent large cities (>100,000 population); small-sized stars represent small cities (<60,000 population).
Table 1. Survey questions asked of Texas physicians concerning pre and post exposure rabies vaccines.
1.
Do you administer pre-exposure rabies vaccine?
2.
Do you administer post exposure rabies vaccine?
3.
Why do you not administer pre-exposure rabies vaccine?
4.
Why do you not administer post exposure rabies vaccine?
5.
Where can a person get pre-exposure rabies vaccine?
6.
Where can a person get post exposure rabies vaccine?
7.
Is the pre-exposure rabies vaccine a single shot or a shot series?
8.
Is the post exposure rabies vaccine a single shot or a shot series?
9
If a series, how many shots are in the pre-exposure series?
10.
If a series, how many shots are in the post exposure series?
11.
Where on the body are the rabies pre-exposure vaccines given?
12.
Where on the body are the rabies post exposure vaccines given?
13.
What side effects can occur with rabies pre-exposure vaccines?
14.
What side effects can occur with rabies post exposure vaccines?
15.
Are pre-exposure vaccines kept in stock or ordered on an individual basis?
16.
Are post exposure vaccines kept in stock or ordered on an individual basis?
17.
To how many patients did you administer pre-exposure rabies vaccine in the last year? Last 5 years?
18.
To how many patients did you administer post exposure rabies vaccine in the last year? Last 5 years?
19.
Where would one get information about rabies vaccines?

377

pre and post exposure rabies vaccine to
during the last year and past 5 years. More
medical providers from small cities within
the rabies endemic area treated more
patients with rabies prophylaxis than
medical providers from the other regions
and city sizes (Figure 2a-d). However, the
majority of medical providers (>95%) did
not have a history of rabies prophylaxis
treatment. Significant differences between
region, city size, and interactive effects were
not noted (x2 < 6.0, df =3, P > 0.14) for the
remaining questions of our survey.

RESULTS
Three hundred forty-four clinics
were contacted, of which 297 medical
providers participated in our survey. Of the
47 non-participatory clinics, a greater
number (x2 = 17.1, df =3, P <0.001) of
medical providers were from large cities
outside the rabies endemic area (75% of the
chi-square value) than the remaining regions
and city sizes.
Significant interactions occurred
between regions and city sizes (x2 > 9.3, df
=3, P <0.03) when medical providers were
asked how many patients they administered
(a)

Number of patients who received pre-exposure rabies
vaccine during last year

% Respondents (N=297)
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Figure 2(a). Percent of respondents (N=297) who stated that they treated patients with pre-exposure rabies
prophylaxis during the last year. No differences were observed between respondents within and outside
rabies endemic zone, city size, or interactive effects.
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(b)

Number of patients who received pre-exposure rabies
vaccine during last 5 years
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Figure 2(b). Percent of respondents (N=297) who stated that they treated patients with pre-exposure rabies
prophylaxis during the last 5 years. The same capital letter within each category for patient number is not
different (P > 0.05).

(c)

Number of patients who received post exposure rabies
vaccine during last year
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Figure 2(c). Percent of respondents (N=297) who stated that they treated patients with post exposure rabies
vaccine during the last year. The same capital letter within each category for patient number is not different
(P > 0.05).
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(d)

Number of patients who received post exposure rabies
vaccine during last 5 years
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Figure 2(d). Percent of respondents (N=297) who stated that they treated patients with post exposure rabies
vaccine during the last 5 years. The same capital letter within each category for patient number is not
different (P > 0.05).

ordered the vaccine on an ‘as needed’ basis.
All medical providers who were willing to
provide post exposure vaccine to their
patients (N = 205) ordered the vaccine on an
‘as needed’ basis. When asked if the preexposure rabies vaccines was a single
injection or a series of injections, 33.3% and
48.1% of the medical providers said the
vaccine was a single shot and shot series,
respectfully, while the remaining providers
either did not know or chose to not respond
to the question. When the same question
was posed concerning the post exposure
vaccine, 0% and 81.8% of the medical
providers said the vaccine was a single shot
and shot series, respectfully, while the
remaining 18.2% of the providers did not
know or chose to not answer the question.
Of the medical providers who responded
that rabies prophylaxis was a series of
injections, 23.9%, 24.2% and 51.9% of the
providers (N = 143) stated that the preexposure vaccine was a series of 2-5 shots,
6-9 shots, and ‘did not know’, respectfully,
while 0.7%, 31.0%, and 68.3% of the
providers (N = 243) stated that the post

In general, medical providers had
varied responses to our questions. Nearly
70% of the 297 medical providers stated that
they would provide post exposure rabies
vaccine to patients; however, only 52%
responded that they also would administer
the pre-exposure prophylaxis.
Answers
varied as to why medical providers (N =
143) did not administer pre-exposure
prophylaxis (Figure 3), but the majority of
medical providers that would not give post
exposure vaccines (58% of 92) stated that
they had no authority to administer the
vaccine (Figure 3). Of the same medical
providers who would not administer rabies
prophylaxis, when asked where a person
could acquire rabies vaccines, the majority
of providers responded that patients should
go to county health offices (41.8% of 143)
and hospitals (66.3% of 92) for pre-exposure
and post exposure rabies vaccines,
respectively (Figure 4). Of the medical
providers who did provide rabies vaccines to
their patients, only 1 of 154 providers
maintained the pre-exposure vaccine in
stock while the vast majority of providers
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exposure vaccines varied widely (Figure 6).
Lastly, when asked where a person should
go to acquire information about rabies
vaccines, 18.2% responded their family
physician, 60.3% said the county health
department, 21.4% said the state health
department, and 0.4% of the 297 medical
providers responded that they did not know.

exposure vaccine was a series of 2-5 shots,
6-9 shots, and ‘did not know’, respectfully.
The majority of medical providers believed
that pre-exposure vaccines are administered
in the arm of patients, while the stomach
was considered the injection site of choice
for post exposure shots by more providers
(Figure 5). Responses by medical providers
concerning the side effects of pre and post

% Respondents

(N=143: Pre-exposure; N=92: Post exposure

Why do you not provide pre- and post exposure rabies vaccines?
70
57.9

60
50
40
29.6

30

26.9

24.9

25.2

20

12.8

11.1

7.1

10
1.7

2

Nonrespondants

0.7

0

0
No time

No authority

Difficult to get

Insurance
liability

Don't know

Responses
Pre-exposure

Post exposure

Figure 3. Reasons given why certain medical providers did not provide pre and post exposure rabies vaccines
to their patients.
Where can a person acquire pre- and post exposure rabies vaccine?

% Respondents

N=143: Pre-exposure; N=92: Post exposure

70
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40
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20
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10
0

3
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State Health Office

Don't Know

Responses
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Figure 4. Places suggested by medical providers who would not provide pre and post exposure vaccines to
their patients as to where the patients could acquire the rabies vaccine.
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Where on the body are pre- and post exposure vaccines given?
70
61.6

58.2

% Respondents (N=297)

60
50
40
30

25.9

22.6

18.8

20

11.4
10
1

0.4

0
Non-respondants
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Stomach

Gluteus

Responses
Pre-exposure
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Figure 5. Injection site locations suggested by medical providers as to where on the body pre and post
exposure rabies vaccines should be given.

What are the side effects to the pre- and post exposure rabies
vaccines?
60

% Respondents (N=297)

51.2
50
39.7
40
33
30
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20.2

24.9

20
10
0.7

0

1.7

5.4
0

0
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Sw elling

0.4

Nausea

Fever

Multiple

Responses
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Post exposure

Figure 6. Side effects suggested by medical providers that can potentially occur after pre and post exposure
rabies vaccines are given.

succumbing to rabies, usually occurring
during western-themed genre. Even Roy
Rogers died of rabies in his last movie role
as a predator trapper on a large Texas ranch.
Little wonder then that many envision rabid
dogs in rural areas when considering rabies.
This ingrained lesson may be partially
responsible for our observance of statistical

DISCUSSION
Despite its rarity in our modern
culture, rabies still invokes a deep fear.
Since antiquity, rabies has been one of the
most feared diseases (Jackson 2002). Many
of these fears were played out before our
eyes as some of our movie and television
heros fought the good fight before
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providers
not
offering
pre-exposure
treatment, insurance liability (25.2%) and
the lack of authority to give these shots
(24.9%) were cited as the leading reasons,
with difficulty in getting vaccine coming in
third (7.1%).
Liability is a concern when
providing most any service, especially if the
service is considered an elective procedure.
Given that rabies exposure is sometimes
achieved without the awareness of the
individual,
classifying
pre-exposure
vaccination as “elective”, and thereby not
readily available, could prove fatal to those
with any risk for exposure. As with all
prescription drugs available legally in the
US, rabies vaccine is manufactured under
FDA regulations and given FDA approval as
safe when used as directed. Briggs (2002)
reported that while allergic reactions have
been reported after booster vaccination, a
maintenance requirement for maintaining
pre-exposure protection, no serious or
lasting medical conditions developed. All
have been treated successfully with
antihistamines, epinephrine, and steroids.
Exactly why medical facilities would look at
rabies vaccine differently from any other
prophylaxes, such as tetanus vaccine, is
unclear and needs to be further studied
within the legal arena.
More puzzling is the feeling that
medical providers did not have the authority
to give pre-exposure rabies vaccine. As a
prescription drug, only doctors can prescribe
it. Many medical providers cited the need to
contact local and state health department
officials for assistance. After calling a small
random
sample
of
county
health
departments, several said that they could
assist in administering the shot series.
However, no department had a doctor on
staff to prescribe the shot series, thus leaving
the first essential step of prescribing the
vaccination to doctors. All county and state
health officials expressed surprise at the “no

significance regarding the number of
physicians from small cities/within the
established rabies zones willing to give pre
and post exposure vaccinations to residents,
when compared to all other groups. Other
reasons might include expanded media
coverage of rabies dues to rabies control
activities occurring within and around their
town, observed economic boosts to the local
economy as rabies control activities are
conducted in their area, and recognition by
local doctors of zoonotic disease concerns
present within the vicinity. Additionally,
enhanced awareness of wildlife and wildlife
issues by residents of small cities, typically
more tied to the land as compared to large,
metropolitan areas, may create a very small,
but continuous demand for rabies treatment.
Figure 3 depicts this small, but steady
demand as observed in the number of shots
given across all categories in the last 5
years.
Pre-Exposure Vaccination
The World Health Organization
(WHO 2002) states that pre-exposure rabies
vaccination should be given to groups of
persons at high risk of exposure to live
rabies virus, including laboratory staff,
veterinarians, animal handlers, wildlife
officers, and others who’s hobbies may
expose them to rabies.
Pre-exposure
prophylaxis is beneficial for the following
reasons: 1) the need for rabies immune
globulin is eliminated, 2) post-exposure
vaccine regimen is reduced from five to two
doses, 3) protection against rabies is
possible if post-exposure treatment (PET) is
delayed, 4) protection against inadvertent
exposure to rabies is possible, and 5) the
cost of PET is reduced (Briggs 2002). In
spite of these easily obtained findings,
roughly half of all respondents indicated that
they did not offer pre-exposure propholaxis.
Reasons given were unexpected at best and
totally confusing at worst.
Of those
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CDC (2005) state that rabies vaccine therapy
should be initiated as soon as possible,
following exposure. Furthermore, WHO
considers PET to constitute an emergency
situation. While emergency care and initial
shots can be initiated at most hospital
emergency rooms, it is important to note that
rabies vaccines are very expensive. CDC
(2003) estimated the cost of a course of
rabies immune globulin and five doses of
vaccine given over a 4 week period typically
exceeds $1000. Wound care, tetanus shot,
and any additional antibiotics needed are in
addition to this figure.
Added costs
associated with emergency room care could
quickly and easily exceed an individual’s
available funds.
Given rabies’ life
threatening potential, health care is a
necessity and availability of treatment at
one’s primary health care facility could help
substantially reduce the associated financial
burden.
Every potential rabies exposure
should be evaluated on a case-by-case basis,
considering the epidemiology of the area,
species involved, type of contact between
victim and suspected rabid animal
(provoked vs. unprovoked), and the
anatomical location and severity of exposure
(Briggs 2002). Need for medical treatment
or non-treatment could then be evaluated
from these results. While this procedure
may take some time away from the usual
stream of common ailments, it can not be
stressed enough of the potential death of a
patient exposed to rabies.
Of our
respondents surveyed who did not treat
patients possibly exposed to rabies, 26.9%
claimed they did not have time to treat them.
Although not specially asked as to the
meaning of the statement, it is assumed that
the amount of time researching necessary
procedures and vaccine procurement would
seriously hamper their ability to provide
health care for all patients. Recognition and
utilization of associated consulting staff at

authority” response and restated their role as
a support role, not the leading force in
controlling disease at the ground level.
Difficulty in obtaining the vaccine
was identified as a reason not to offer the
vaccination series. In reality, pre-exposure
vaccine is kept in stock and available at all
state health regional offices and many
county health offices across the state (Tom
Sidwa, Texas Dept. of Health personal
communication 2005).
Additionally,
vaccine can be ordered from the
manufacturer directly by toll free numbers
supplied by state heath officials and listed
on the Centers for Disease Control (CDC)
website (www.cdc.gov/ncidod/dvrd/rabies/
professional/professi.htm). CDC also offers
a 24 hours a day/7 days a week information
line for physicians, nurses, pharmacists,
veterinarians, and other health officials that
have questions about rabies and rabies
prophylaxis.
Post-Exposure Treatment
Rabies is a unique neurologic
infection that can be prevented by PET, at
least when the vaccine is administered to
patients within a reasonable period of time
after a rabies exposure (Lafon 2002).
However, nearly one-third of our
respondents did not offer PET. A shocking
60% felt they had no authority to administer
the treatment regimen followed by an
equally shocking response by 26.9% that
they did not have time. These attitudes are
not particularly helpful to someone that has
been exposed to rabies, a potentially fatal
disease.
As stated earlier, it is difficult to
understand exactly how doctors came to
believe they have no authority to prescribe a
vaccine to combat a medical condition.
Whether this is specific to rabies or extends
to other diseases is unknown. However, it is
particularly troubling given the urgent need
for medical care. Both WHO (2002) and
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one should attempt to get information about
this important disease.
To resolve
confusion, information packets need to be
developed and distributed to family
physicians. Aided by a quick reference,
medical personnel could cut their research
time significantly, disseminate correct
information to the patient, and be guided by
experts when making important rabies
treatment decisions. To spare expense, hard
copies could be distributed periodically,
with the Texas Department of Health’s
website serving as the appropriate place to
get up to date information between hard
copy printings.
Information sharing
between health officials and physicians is
paramount to adequately protecting Texas
residents from this rare, but ever present
disease.

local and/or state health departments, as well
as CDC’s rabies support hotline, would
greatly reduce the time burden possibly felt
by uninformed health care providers.
The percentage of providers who did
not treat rabies exposures seem consistent
with the number of providers that gave
incorrect answers to how rabies vaccinations
are given. Results in Figure 5 showed that
while most providers understood rabies
treatments (pre and post-exposure) were
given as a series of shots, most were
confused as to where the shots were given.
Older vaccines were given in a variety of
locations, including the stomach region. In
1980, a new vaccine was licensed by FDA
for use in rabies treatment in the US
(Vodopija and Clark 2000). Currently, all
vaccine is given in the deltoid region of the
arm for adults and can be administered in
the thigh area for children. Our results
indicated that over half (58.2%) believed
that PET was still given in the stomach,
while 22.6% believed them to be given in
the gluteus. WHO (2002) stated that neither
the pre nor post-exposure shots should ever
be given in the gluteal region and Briggs
(2002) added that shots in the gluteal area
may lead to lower antibody levels and
failure of PET. Ironically, a recent San
Antonio new story told of a south Texas
child, exposed to a rabid animal, as facing a
series of shots in the stomach (Gary Nunley,
USDA-APHIS-WS, personal communication 2005). Even after 25 years, the
perceived discomfort of shots in the stomach
is apparently hard to remove from the
American psyche.
Lastly, when asked where one should
go to get information about rabies vaccines,
81.7 % indicated that either state or county
health departments could provide this
information. Only 18.2% respondents felt
one could get information from their family
physician. Consistent with our findings,
family doctors may indeed be the last place

CONCLUSION
Rabies is endemic in several wildlife
species in Texas, making human exposure a
rare, but real threat to human life. Many
residents, not educated in the disease, its
prevention, and/or its treatment, are
dependent on their medical providers to
provide swift and complete medical
treatment.
Unfortunately, our survey
indicated that many primary care medical
personnel throughout Texas are equally
deficient in their knowledge of the virus,
resulting in a serious reduction of treatment
outlets for exposure cases. A state-wide
educational program, targeted at medical
providers, needs to be implemented to
increase awareness of rabies prophylactic
procedures and treatment.
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